Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gritstone Bio Inc (NQ: GRTS )

0.7437 -0.0015 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gritstone Bio Inc

< Previous 1 2 3 4 Next >
Nasdaq Down Over 1%; VivoPower International Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down 1.07% to 39,142.53 while the NASDAQ fell 1.14% to 16,209.12. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Crude Oil Surges Over 1%; US Factory Orders Increase In February
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 1.05% to 39,152.47 while the NASDAQ fell 1.17% to 16,205.37. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?
Preliminary data released by Gritstone bio reveals results for GRANITE, a personalized neoantigen cancer vaccine, in treating metastatic microsatellite stable colorectal cancer. 
Via Benzinga
Why Are Health Insurance Stocks HUM, UNH, CI Down Today?
Health insurance stocks are falling Tuesday after the Biden Administration announced it won't increase Medicare Advantage rates for 2025. 
Via InvestorPlace
Ubisoft Layoffs 2024: What to Know About the Latest Round of Ubisoft Job Cuts
Ubisoft layoffs were announced for 45 of the company's employees as it streamlines its global publishing and Asia-Pacific units. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Dow Dips Over 400 Points; Paychex Posts Downbeat Sales
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 400 points on Tuesday. Following the market opening Tuesday, the Dow traded down 1.08% to 39,140.90 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
GOEV Stock Alert: Canoo Announces Expansion Into Saudi Arabia
Canoo stock is falling on Tuesday even as GOEV investors in the EV company learn of its latest expansion into Saudi Arabia. 
Via InvestorPlace
Why Is Gritstone Bio (GRTS) Stock Down 44% Today?
Gritstone Bio stock is falling on Tuesday after the biotechnology company priced an underwritten public offering for GRTS shares. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of VirTra, Inc. (NASDAQ: VTSI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday! 
Via InvestorPlace
Paychex, PVH And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
3 Speculative Stocks You Can Buy for $3 or Less
Although speculative stocks below $3 aren’t for everyone, these small-cap enterprises could potentially pull off some surprises. 
Via InvestorPlace
GRTS Stock Earnings: Gritstone Bio Beats EPS, Beats Revenue for Q4 2023
GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Gritstone Bio Stock Trading Lower?
Gritstone Bio faces challenges with a 40% workforce reduction due to delays in the CORAL Phase 2b study and a funding setback. Despite this, Gritstone remains committed to its core programs, with... 
Via Benzinga
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up. 
Via InvestorPlace
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.